Atlas Trials

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Clinical trial NCT06208878 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06208878
Sponsor
CRISPR Therapeutics AG
Status
ENROLLING_BY_INVITATION
Study type
OBSERVATIONAL
Hematologic MalignancySolid Malignancy
Start date
2023-11-22
Primary completion
2038-08-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.